BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 19, 2004
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Genentech Inc.

(DNA), South San Francisco, Calif.

Business: Biopharmaceuticals

Deutsche Bank analyst Dennis Harp lowered his rating to "hold" from "buy" based on valuation. He said the company has a PEG ratio...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >